Redmile Group as of June 30, 2023
Portfolio Holdings for Redmile Group
Redmile Group holds 72 positions in its portfolio as reported in the June 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
ImmunoGen | 12.8 | $335M | 18M | 18.87 | |
Krystal Biotech (KRYS) | 11.6 | $301M | 2.6M | 117.40 | |
Amicus Therapeutics (FOLD) | 9.4 | $246M | 20M | 12.56 | |
Replimune Group (REPL) | 3.9 | $103M | 4.4M | 23.22 | |
Akero Therapeutics (AKRO) | 3.2 | $85M | 1.8M | 46.69 | |
Augmedix (AUGX) | 2.9 | $75M | 16M | 4.81 | |
Deciphera Pharmaceuticals (DCPH) | 2.6 | $69M | 4.9M | 14.08 | |
Fate Therapeutics (FATE) | 2.4 | $63M | 13M | 4.76 | |
Celldex Therapeutics Com New (CLDX) | 2.2 | $58M | 1.7M | 33.93 | |
Livanova SHS (LIVN) | 2.2 | $57M | 1.1M | 51.43 | |
Catalent (CTLT) | 1.9 | $50M | 1.2M | 43.36 | |
Zymeworks Del (ZYME) | 1.9 | $49M | 5.7M | 8.64 | |
Pliant Therapeutics (PLRX) | 1.9 | $49M | 2.7M | 18.12 | |
Penumbra (PEN) | 1.8 | $48M | 139k | 344.06 | |
Beam Therapeutics (BEAM) | 1.8 | $47M | 1.5M | 31.93 | |
Xenon Pharmaceuticals (XENE) | 1.7 | $43M | 1.1M | 38.50 | |
Kymera Therapeutics (KYMR) | 1.6 | $43M | 1.9M | 22.99 | |
BioMarin Pharmaceutical (BMRN) | 1.6 | $42M | 489k | 86.68 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.6 | $42M | 342k | 123.97 | |
Stoke Therapeutics (STOK) | 1.6 | $42M | 4.0M | 10.63 | |
Regenxbio Inc equity us cm (RGNX) | 1.6 | $41M | 2.0M | 19.99 | |
Dex (DXCM) | 1.4 | $37M | 289k | 128.51 | |
Immunovant (IMVT) | 1.4 | $36M | 1.9M | 18.97 | |
Anthem (ELV) | 1.3 | $35M | 78k | 444.29 | |
Scholar Rock Hldg Corp (SRRK) | 1.3 | $33M | 4.4M | 7.54 | |
Ventyx Biosciences (VTYX) | 1.2 | $31M | 941k | 32.80 | |
Adc Therapeutics Sa SHS (ADCT) | 1.2 | $30M | 14M | 2.15 | |
Nurix Therapeutics (NRIX) | 1.1 | $29M | 2.9M | 9.99 | |
Igm Biosciences (IGMS) | 1.1 | $27M | 3.0M | 9.23 | |
Stryker Corporation (SYK) | 1.0 | $26M | 86k | 305.09 | |
Repare Therapeutics Ord (RPTX) | 1.0 | $26M | 2.4M | 10.58 | |
Cogent Biosciences (COGT) | 0.9 | $24M | 2.1M | 11.84 | |
Charles River Laboratories (CRL) | 0.9 | $24M | 114k | 210.25 | |
Zimmer Holdings (ZBH) | 0.8 | $22M | 151k | 145.60 | |
Iqvia Holdings (IQV) | 0.8 | $21M | 94k | 224.77 | |
Boston Scientific Corporation (BSX) | 0.8 | $21M | 391k | 54.09 | |
Humana (HUM) | 0.8 | $21M | 46k | 447.13 | |
Verve Therapeutics (VERV) | 0.8 | $20M | 1.1M | 18.75 | |
Entrada Therapeutics (TRDA) | 0.8 | $20M | 1.3M | 15.14 | |
Prime Medicine (PRME) | 0.7 | $19M | 1.3M | 14.65 | |
Cabaletta Bio (CABA) | 0.7 | $18M | 1.4M | 12.91 | |
Shattuck Labs (STTK) | 0.7 | $18M | 5.6M | 3.12 | |
89bio (ETNB) | 0.6 | $14M | 762k | 18.95 | |
Gritstone Oncology Ord (GRTS) | 0.5 | $13M | 6.9M | 1.95 | |
Annexon (ANNX) | 0.5 | $12M | 3.5M | 3.52 | |
Absci Corp (ABSI) | 0.5 | $12M | 8.0M | 1.52 | |
Allakos (ALLK) | 0.4 | $10M | 2.3M | 4.36 | |
Stereotaxis Com New (STXS) | 0.4 | $9.8M | 6.4M | 1.53 | |
Atara Biotherapeutics (ATRA) | 0.4 | $9.7M | 6.0M | 1.61 | |
Alx Oncology Hldgs (ALXO) | 0.4 | $9.6M | 1.3M | 7.51 | |
Medavail Holdings Ord | 0.3 | $8.5M | 35M | 0.25 | |
Rapt Therapeutics (RAPT) | 0.3 | $8.1M | 432k | 18.70 | |
Acelyrin (SLRN) | 0.3 | $7.6M | 365k | 20.90 | |
Stevanato Group S P A Ord Shs (STVN) | 0.3 | $7.1M | 218k | 32.38 | |
Allovir (ALVR) | 0.2 | $6.5M | 1.9M | 3.40 | |
Evolent Health Cl A (EVH) | 0.2 | $6.5M | 213k | 30.30 | |
Mersana Therapeutics (MRSN) | 0.2 | $5.6M | 1.7M | 3.29 | |
Grifols S A Sp Adr Rep B Nvt (GRFS) | 0.2 | $5.5M | 601k | 9.16 | |
Nuvation Bio Com Cl A (NUVB) | 0.2 | $5.5M | 3.0M | 1.80 | |
Somalogic Class A Com | 0.2 | $4.3M | 1.9M | 2.31 | |
Lava Therapeutics Nv SHS (LVTX) | 0.2 | $4.2M | 2.1M | 2.03 | |
Science 37 Holdings | 0.2 | $4.2M | 20M | 0.21 | |
Hookipa Pharma Inc equity (HOOK) | 0.1 | $2.9M | 3.3M | 0.88 | |
Xeris Pharmaceuticals (XERS) | 0.1 | $2.7M | 1.0M | 2.62 | |
Invitae (NVTAQ) | 0.1 | $2.6M | 2.3M | 1.13 | |
Neoleukin Therapeutics | 0.1 | $2.4M | 2.9M | 0.83 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $1.5M | 1.6M | 0.95 | |
Adagio Therapeutics (IVVD) | 0.1 | $1.5M | 1.4M | 1.05 | |
Alpha Teknova (TKNO) | 0.0 | $825k | 309k | 2.67 | |
Sonendo (SONX) | 0.0 | $678k | 498k | 1.36 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.0 | $662k | 716k | 0.93 | |
Atreca Cl A Com (BCEL) | 0.0 | $434k | 443k | 0.98 |